Terrance McGuire, 10% Owner at Lyra Therapeutics, Inc. (LYRA), bought 90,368 shares at $16.00 ($1.2M) on 2020-05-05, disclosed to the SEC on 2020-05-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,936 | $0 | 0.0% |
| 2 | $8.63 | 173 | $1K | 0.1% |
| 3 | $8.63 | 337 | $3K | 0.3% |
| 4 | $8.63 | 17,304 | $149K | 12.9% |
| 5 | $8.63 | 118 | $1K | 0.1% |
| 6 | $16.00 | 60,308 |
| $965K |
| 83.6% |
| 7 | $16.00 | 413 | $7K | 0.6% |
| 8 | $16.00 | 603 | $10K | 0.8% |
| 9 | $16.00 | 1,176 | $19K | 1.6% |
| Total | $12.78 avg | 90,368 | $1.2M | 100% |
| Filing → |
| IVVD | SELL | 2024-12-26 | $215K | — | Filing → |
| IVVD | SELL | 2024-12-19 | $213K | — | Filing → |
| IVVD | SELL | 2024-12-16 | $103K | — | Filing → |